Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: ADJUVANTES IMUNOLÓGICOS
ABNT
SILVA, Nayara Aparecida de Oliveira e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 19 abr. 2024. , 2015APA
Silva, N. A. de O., Ribeiro, A. G., & Kano, E. K. (2015). Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Silva NA de O, Ribeiro AG, Kano EK. Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 32 res. FCF060.[citado 2024 abr. 19 ]Vancouver
Silva NA de O, Ribeiro AG, Kano EK. Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 32 res. FCF060.[citado 2024 abr. 19 ]